Literature DB >> 19166911

Activation of toll-like receptor-3 induces interferon-lambda expression in human neuronal cells.

L Zhou1, X Wang, Y J Wang, Y Zhou, S Hu, L Ye, W Hou, H Li, W Z Ho.   

Abstract

We examined the gene expression and regulation of type III human interferon (IFN), IFN-lambda, in human neuronal cells. Human neuronal cells expressed endogenous IFN-lambda1 but not IFN-lambda2/3. Upon the activation of Toll-like receptor (TLR)-3 expressed in the neuronal cells by polyriboinosinic polyribocytidylic acid (PolyI:C), both IFN-lambda1 and IFN-lambda2/3 expression was significantly induced. The activation of TLR-3 also exhibited antiviral activity against pseudotyped human immunodeficiency virus (HIV)-1 infection of the neuronal cells. Human neuronal cells also expressed functional IFN-lambda receptor complex, interleukin-28 receptor alpha subunit (IL-28Ralpha) and IL-10Rbeta, as evidenced by the observations that exogenous IFN-lambda treatment inhibited pseudotyped HIV-1 infection of the neuronal cells and induced the expression of apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC)3G/3F, the newly identified anti-HIV-1 cellular factors. These data provide direct and compelling evidence that there is intracellular expression and regulation of IFN-lambda in human neuronal cells, which may have an important role in the innate neuronal protection against viral infections in the CNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166911      PMCID: PMC2650740          DOI: 10.1016/j.neuroscience.2008.12.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  51 in total

1.  Influence of adrenaline on the dissemination of antibody-producing cells from the spleen.

Authors:  U Ernström; O Söder
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

2.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

3.  Interleukin-1beta stimulates macrophage inflammatory protein-1alpha and -1beta expression in human neuronal cells (NT2-N).

Authors:  Chang-Jiang Guo; Steven D Douglas; Jian-Ping Lai; David E Pleasure; Yuan Li; Marge Williams; Peter Bannerman; Li Song; Wen-Zhe Ho
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

4.  Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.

Authors:  Julie K Olson; Stephen D Miller
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

5.  Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.

Authors:  Chang-Jiang Guo; Steven D Douglas; Zhiyong Gao; Bryan A Wolf; Judith Grinspan; Jian-Ping Lai; Eric Riedel; Wen-Zhe Ho
Journal:  Glia       Date:  2004-11-15       Impact factor: 7.452

6.  Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.

Authors:  Shekar Srinivas; Jihong Dai; Joyce Eskdale; Grant E Gallagher; Nicholas J Megjugorac; Grant Gallagher
Journal:  Immunology       Date:  2008-06-10       Impact factor: 7.397

7.  Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells.

Authors:  Eliana M Coccia; Martina Severa; Elena Giacomini; Danièle Monneron; Maria Elena Remoli; Ilkka Julkunen; Marina Cella; Roberto Lande; Gilles Uzé
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

Review 8.  The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain.

Authors:  Raymond P Donnelly; Faruk Sheikh; Sergei V Kotenko; Harold Dickensheets
Journal:  J Leukoc Biol       Date:  2004-05-03       Impact factor: 4.962

9.  Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway.

Authors:  Seija Lehnardt; Leon Massillon; Pamela Follett; Frances E Jensen; Rajiv Ratan; Paul A Rosenberg; Joseph J Volpe; Timothy Vartanian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-24       Impact factor: 11.205

10.  Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.

Authors:  Laure Dumoutier; Amel Tounsi; Thomas Michiels; Caroline Sommereyns; Sergei V Kotenko; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

View more
  29 in total

Review 1.  Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor.

Authors:  Wen-Yan Cui; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

Review 2.  Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.

Authors:  Nicole E Pagliaccetti; Michael D Robek
Journal:  J Interferon Cytokine Res       Date:  2010-08       Impact factor: 2.607

3.  IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons.

Authors:  Lin Zhou; Jieliang Li; Xu Wang; Li Ye; Wei Hou; Jie Ho; He Li; Wenzhe Ho
Journal:  J Neurovirol       Date:  2011-04-16       Impact factor: 2.643

4.  Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons.

Authors:  Jieliang Li; Shuxian Hu; Lin Zhou; Li Ye; Xu Wang; Jie Ho; Wenzhe Ho
Journal:  Glia       Date:  2010-09-27       Impact factor: 7.452

5.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

6.  Clustered and genome-wide transient mutagenesis in human cancers: Hypermutation without permanent mutators or loss of fitness.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Bioessays       Date:  2014-02-26       Impact factor: 4.345

7.  Induction of interferon-γ contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes.

Authors:  Jieliang Li; Li Ye; Xu Wang; Shuxian Hu; Wenzhe Ho
Journal:  J Neurosci Res       Date:  2011-11-04       Impact factor: 4.164

8.  Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells.

Authors:  Wen-Yan Cui; Ju Wang; Jinxue Wei; Junran Cao; Sulie L Chang; Jun Gu; Ming D Li
Journal:  Amino Acids       Date:  2011-12-21       Impact factor: 3.520

9.  Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.

Authors:  Julia Diegelmann; Florian Beigel; Kathrin Zitzmann; Artur Kaul; Burkhard Göke; Christoph J Auernhammer; Ralf Bartenschlager; Helmut M Diepolder; Stephan Brand
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

10.  Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages.

Authors:  Jieliang Li; Yizhong Wang; Xu Wang; Li Ye; Yu Zhou; Yuri Persidsky; Wenzhe Ho
Journal:  Blood       Date:  2013-02-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.